Why the study?
Platelet-to-lymphocyte ratio may be useful in predicting the development and control of type 2 diabetes mellitus, but its correlation with HbA1c required validation.
Can the platelet-to-lymphocyte ratio (PLR) predict the development and control levels of type 2 diabetes mellitus?
Can the platelet-to-lymphocyte ratio (PLR) predict the development and control levels of type 2 diabetes mellitus?
PLR may serve as an inexpensive and accessible biomarker for predicting type 2 diabetes development and glycemic control.
Should not yet change T2DM screening practices; hypothesis-generating for PLR as biomarker needing prospective validation.
As an inexpensive and easy to use index, PLR may be useful in predicting the development and control levels of type 2 diabetes mellitus. However, its correlation with HbA1c needs to be validated by larger prospective studies.
No takes yet. Share an insight, caveat, or question.
Tel et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: